EBITDA: Income before interest, taxes, depreciation and amortization.
Evogene Ltd. (EVGN) had EBITDA of $-2.11M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.31M |
|
$3.87M |
|
$0.16M |
|
$0.15M |
|
$3.04M |
|
$-2.72M |
|
$-0.00M |
|
$-2.73M |
|
$-2.73M |
|
$-2.73M |
|
$-2.73M |
|
$5.20M |
|
$-2.73M |
|
$-2.72M |
|
|
EBITDA |
$-2.11M |
8.72M |
|
8.72M |
|
$0.44 |
|
$0.44 |
|
| Balance Sheet Financials | |
$20.83M |
|
$1.20M |
|
$5.25M |
|
$26.09M |
|
$4.08M |
|
-- |
|
$4.76M |
|
$8.83M |
|
$17.25M |
|
$17.25M |
|
$17.25M |
|
8.72M |
|
| Cash Flow Statement Financials | |
$-10.82M |
|
$7.47M |
|
$-6.35M |
|
$15.30M |
|
$5.63M |
|
$-9.68M |
|
$0.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.11 |
|
-- |
|
-- |
|
-- |
|
-- |
|
49.68% |
|
-873.08% |
|
-873.08% |
|
-- |
|
-874.36% |
|
1241.67% |
|
$-10.91M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.07 |
|
0.16 |
|
574.90 |
|
-15.82% |
|
-15.82% |
|
-10.46% |
|
-15.82% |
|
$1.98 |
|
$-1.25 |
|
$-1.24 |
|